Bristol-Myers makes final cuts in Wallingford
Photo | Contributed
The Bristol-Myers Squibb research complex in Wallingford, which the company plans to vacate at the end of this year.
Drugmaker Bristol-Myers Squibb (BMS) has notified the state of a final round of layoffs ahead of shutting down its operations in Wallingford. A total of 86 workers will be laid off between Nov. 13 and Dec. 31, the date of the facility’s closure, according to the company’s filing with the Connecticut Department of Labor.
BMS announced in Dec. 2016 that it would cease operations at its 5 Research Parkway facility in Wallingford, where it employed about 700 people at the time. As of February of this year, 400 employees remained with several rounds of layoffs to go.
Despite closing in Connecticut, the company has said it would invest in new construction in Lawrenceville and New Brunswick, N.J.; and continue to expand its Devens, Mass., biologics campus. It is also expanding in Cambridge and the San Francisco Bay Area.
Most Recent
Most Recent
0 Comments